Home Insight Page 9

Top Stories in Insight

Batten down the hatches

Editorial

  • By: IE Staff
  • May 3, 2019 November 12, 2019
  • 00:01

Attack of the premiers

Andrew Scheer may lead the federal Conservatives, but Jason Kenney and Doug Ford have set the narrative for the October federal election

Focus on the achievable

Editorial

“Don’t forget the budget”

The Liberals want voters to keep thinking about the budget — and not the SNC-Lavalin scandal

A new era of enforcement

Editorial

  • By: IE Staff
  • March 8, 2019 November 12, 2019
  • 15:01

Why the change of heart?

The SNC-Lavalin affair deserves a royal commission, but not for the reason most people would expect

Markets need robust rules

Editorial

  • By: IE Staff
  • February 12, 2019 November 12, 2019
  • 00:01

The pipeline problem

Ottawa and the provinces must deal with Indigenous peoples and investors in an open-handed way

Populism rattles financial markets

In this age of rising populism and partisanship, the value of expertise and institutions increasingly is under siege. And that trend threatens economic growth and…

  • By: IE Staff
  • January 21, 2019 November 12, 2019
  • 00:01

Advantage: Trudeau – for now

Ottawa

Dear Investment Executive reader

We apologize for this week’s web troubles

  • By: IE Staff
  • December 7, 2018 November 17, 2019
  • 09:15

National regulator losing its lustre

Editorial

  • November 23, 2018 November 12, 2019
  • 00:01

Getting emotional about carbon

Pierre Trudeau learned in 1972 that he could be a prophet or a politician, but he couldn't be both

Bare trust debacle makes fools of the law-abiding

Editorial: Last-minute policy reversals undermine an already fragile trust between tax authorities and the public

  • By: IE Staff
  • March 29, 2024 March 29, 2024
  • 12:38

Guardian Capital acquires majority of Ontario investment counselling firm

CEO Ken Rae sells his stake but stays on as key leader

Pharmacare a promise Trudeau might come to regret

The Liberals’ re-election prospects look promising thanks to the co-operation of Big Pharma

What investors can expect in 2025

Uncertain policy backdrop, divergence among central banks and risk of re-emerging inflation are forecast to shape the investing landscape

Help your client sell their beneficial interest in an estate

Here’s your helpful guide to advising clients on a complex estate sales process

It’s time to re-evaluate U.S. equities allocation

High valuations and market concentration are headwinds for future returns

Letter: A déjà vu moment for bank sales practices

New review must be approached with urgency, transparency and a commitment to meaningful action, writes Harvey Naglie

Letter: OSC’s proposed disgorgement provisions are unfair and inadequate

A better solution is to start a compensation fund, writes lawyer Joseph Groia 

Letter: A case for rethinking investor education

Behavioural design is no silver bullet, writes Harvey Naglie